Advertisement

Environmental Science and Pollution Research

, Volume 23, Issue 11, pp 10615–10629 | Cite as

Simvastatin effects on detoxification mechanisms in Danio rerio embryos

  • V. Cunha
  • M. M. Santos
  • P. Moradas-Ferreira
  • M. Ferreira
Review Article

Abstract

The transcription and protein activity of defence mechanisms such as ABC transporters, phase I and II of cellular detoxification and antioxidant enzymes can be altered in the presence of emerging contaminants such as pharmaceuticals impacting the overall detoxification mechanism. The present work aimed to characterise the effects of simvastatin on the detoxification mechanisms of embryonic stages of Danio rerio. In a first approach, constitutive transcription of key genes involved in detoxification was determined. Embryos were collected at different developmental stages, and transcription patterns of genes coding for ABC transporters, phase I and II and oxidative stress were analysed. With exception of abcc2, all genes seem to be from maternal transfer (0–2 hpf). Embryos were then exposed to different concentrations of simvastatin (5 and 50 μg/L), verapamil and MK571 (10 μM; ABC protein inhibitors) and a combination of simvastatin and ABC inhibitors. mRNA expression levels of abcb4, abcc1, abcc2, abcg2, cyp1a, cyp3a65, gst, sod, cat was evaluated. Accumulation assays to measure ABC proteins activity and activity of EROD, GST, CAT and Cu/ZnSOD, were also undertaken. Simvastatin acted as a weak inhibitor of ABC proteins and increased EROD and GST activity, whereas Cu/ZnSOD and CAT activity were decreased. Simvastatin up-regulated abcb4 and cyp3a65 transcription (both concentrations), as well as abcc1 and abcc2 at 50 μg/L, and down-regulated gst, sod, cat at 5 μg/L. In conclusion, our data revealed the interaction of simvastatin with detoxification mechanisms highlighting the importance of monitoring the presence of this emerging contaminant in aquatic environments.

Keywords

Simvastatin Zebrafish embryos ABC transporters Phase I and II Biotransformation Antioxidant enzymes 

Notes

Acknowledgments

The authors are thankful to Hugo Santos, Olga Martinez and Ricardo Lacerda for the technical assistance provided in the maintenance of the aquaria. Authors also thank Miguel Semedo, Ricardo Capela and Tiago Torres for the help with the samples. This study was funded by the Portuguese Science and Technology Foundation (FCT) through a fellowship to Virgínia Cunha (SFRH/BD/77931/2011), FCT project PTDC/MAR/098791/2008 and UID/Multi/04423/2013.

Compliance with ethical standards

Conflict of interest

The authors declare that they do not have any conflict of interest.

Contributors

Virgínia Cunha participated in the experimental design and practical work, analysis and interpretation of data and writing of the paper. Marta Ferreira participated in the experimental design, analysis and interpretation of data and along with Miguel Santos and Pedro Moradas-Ferreira that contributed to the article preparation by revising it critically.

Supplementary material

11356_2016_6547_MOESM1_ESM.docx (943 kb)
Supplementary file 1 (DOCX 943 kb)

References

  1. Abrams EW, Mullins MC (2009) Early zebrafish development: it’s in the maternal genes. Curr Opin Genet Dev 19(4):396–403CrossRefGoogle Scholar
  2. Banni M, Chouchene L, Said K, Kerkeni A, Messaoudi I (2011) Mechanisms underlying the protective effect of zinc and selenium against cadmium-induced oxidative stress in zebrafish Danio rerio. Biometals 24:981–992CrossRefGoogle Scholar
  3. Bard SM (2000) Multixenobiotic resistance as a cellular defense mechanism in aquatic organisms. Aquat Toxicol 48:357–389CrossRefGoogle Scholar
  4. Bogman K, Peyer AK, Török M, Küsters E, Drewe J (2001) HMG-CoA reductase inhibiors and P-glycoprotein modulation. Br J Pharm 132:1183–1192CrossRefGoogle Scholar
  5. Bound JP, Voulvoulis N (2004) Pharmaceuticals in the aquatic environment—a comparison of risk assessment strategies. Chemosphere 56(11):1143–1155CrossRefGoogle Scholar
  6. Caminada D, Zaja R, Smital T, Fent K (2008) Human pharmaceuticals modulate P-gp1 (ABCB1) transport activity in the fish cell line PLHC-1. Aquat Toxicol 90:214–222CrossRefGoogle Scholar
  7. Castro LF, Santos MM (2014) To bind or not to bind: the taxonomic scope of nuclear receptor mediated endocrine disruption in invertebrate phyla. Environ Sci Technol 48(10):5361–5363CrossRefGoogle Scholar
  8. Corcoran J, Winter MJ, Tyler CR (2010) Pharmaceuticals in the aquatic environment: a critical review of the evidence for health effects in fish. Crit Rev Toxicol 40(4):287–304CrossRefGoogle Scholar
  9. Costa J, Reis-Henriques MA, Castro LF, Ferreira M (2012a) ABC transporters, CYP1A and GSTα gene transcription patterns in developing stages of the Nile tilapia (Oreochromis niloticus). Gene 506:317–324CrossRefGoogle Scholar
  10. Costa J, Reis-Henriques MA, Castro LFC, Ferreira M (2012b) Gene expression analysis of ABC efflux transporters, CYP1A and GSTα in Nile tilapia after exposure to benzo(a)pyrene. Comp Biochem Physiol C Toxicol Pharmacol 155:469–482CrossRefGoogle Scholar
  11. Dahl U, Gorokhova E, Breitholtz M (2006) Applicaton of growth-related sublethal endpoints in ecotoxicological assessments using a harpacticoid copepod. Aquat Tox 77:433–438CrossRefGoogle Scholar
  12. Eckford PD, Sharom FJ (2008) Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport. Biochemistry 47(51):13686–13698CrossRefGoogle Scholar
  13. Ellesat KS, Yazdani M, Holth TF, Hylland K (2011) Species-dependent sensitivity to contaminants: an approach using primary hepatocyte cultures with three marine fish species. Mar Environ Res 72(4):216–224CrossRefGoogle Scholar
  14. Ellesat KS, Holt TF, Wojewodzic MW, Hylland K (2012) Atrovastatin up-regulate toxicologically relevant genes in rainbow trout gills. Ecotoxicology 21:1841–1856CrossRefGoogle Scholar
  15. Ellis LC, Hawksworth GM, Weaver RJ (2013) ATP-dependent transport of statins by human and rat MRP2/Mrp2. Toxicol Appl Pharmacol 269(2):187–194CrossRefGoogle Scholar
  16. Epel D, Lukebach T, Stevenson CH, MacManus-Spencer LA, Hamdoun A, Smital T (2008) Efflux transporters: newly appreciated roles in protection against pollutants. Environ Sci Tech 42:3914–3920CrossRefGoogle Scholar
  17. Faria M, Navarro A, Luckenbach T, Piña B, Barata C (2011) Characterization of the multixenobiotic resistance (MXR) mechanism in embryos and larvae of the zebra mussel (Dreissena polymorpha) and studies on its role in tolerance to single and mixture combinations of toxicants. Aquat Toxicol 101:78–87CrossRefGoogle Scholar
  18. Fernandes D, Andreu-Sánchez O, Bebianno MJ, Porte C (2008) Assessment of pollution along the Northern Iberian shelf by the combined use of chemical and biochemical markers in two representative fish species. Environ Pollut 155:327–335CrossRefGoogle Scholar
  19. Ferreira M, Moradas-Ferreira P, Reis-Henriques MA (2005) Oxidative stress biomarkers in two resident species, mullet (Mugil cephalus) and flounder (Platichthys flesus), from a polluted site in River Douro Estuary, Portugal. Aquat Toxicol 71(1):39–48CrossRefGoogle Scholar
  20. Ferreira M, Caetano M, Costa J, Pousão-Ferreira P, Vale C, Reis-Henriques MA (2008) Metal accumulation and oxidative stress responses in, cultured and wild, white seabream from Northwest Atlantic. Sci Total Environ 407:638–646CrossRefGoogle Scholar
  21. Ferreira M, Costa J, Reis-Henriques MA (2014a) ABC transporters in fish species: a review. Front Physiol 5:266CrossRefGoogle Scholar
  22. Ferreira M, Santos P, Rey-Salgueiro L, Zaja R, Reis-Henriques MA, Smital T (2014b) The first demonstration of CYP1A and the ABC protein(s) gene expression and activity in European seabass (Dicentrarchus labrax) primary hepatocytes. Chemosphere 100:152–159CrossRefGoogle Scholar
  23. Filby AL, Tyler CR (2007) Appropriate ‘housekeeping’ genes for use in expression profiling the effects of environmental estrogens in fish. BMC Mol Biol 8, e10CrossRefGoogle Scholar
  24. Fischer S, Klüver N, Burkhardt-Medicke K, Pietsch M, Schmidt AM, Wellner P, Schirmer K, Luckenbach T (2013) Abcb4 acts as multixenobiotic transporter and active barrier against chemical uptake in zebrafish (Danio rerio) embryos. BMC Biol 17(11):69CrossRefGoogle Scholar
  25. Gröner F, Ziková A, Kloas W (2015) Effects of the pharmaceuticals diclofenac and metoprolol on gene expression levels of enzymes of biotransformation, excretion pathways and estrogenicity in primary hepatocytes of Nile tilapia (Oreochromis niloticus). Comp Biochem Physiol C Toxicol Pharmacol 167:51–57CrossRefGoogle Scholar
  26. Hernando MD, Mezcua M, Fernández-Alba AR, Barceló D. (2006) Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 69(2):334–42Google Scholar
  27. Hirano M, Maeda K, Matsushima S, Nozaki Y, Kusuhara H, Sugiyama Y (2005) Involvement of BCRP (ABCG2) in the biliary excretion of pitavastatin. Mol Pharmacol 68(3):800–807Google Scholar
  28. Holtzman CW, Wiggins BS, Spinler SA (2006) Role of P-glycoprotein in statin drug interactions. Pharmacotherapy 26(11):1601–1607CrossRefGoogle Scholar
  29. Hsieh CH, Jeng SF, Hsieh MW, Chen YC, Rau CS, Lu TH, Chen SS (2008) Statin-induced heme oxygenase-1 increases NF-kappa B activation and oxygen radical production in cultured neuronal cells exposed to lipopolysaccharide. Toxicol Sci 102(1):150–159CrossRefGoogle Scholar
  30. Key PB, Hoguet J, Reed LA, Chung KW, Fulton MH (2008) Effects of the statin antihyperlipidemic agent simvastatin on grass shrimp, Palaemonetes pugio. Environ Toxicol 23:153–160CrossRefGoogle Scholar
  31. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. (1995) Stages of embryonic development of the zebrafish. Dev Dyn. 203(3):253–310Google Scholar
  32. Kimura Y, Kioka N, Kato H, Matsuo M, Ueda K (2007) Modulation of drug-stimulated ATPase activity of human MDR1/P-glycoprotein by cholesterol. Biochem J 401(2):597–605CrossRefGoogle Scholar
  33. Knauer MJ, Urquhart BL, Schwabedissen H, Schwarz UI, Lemke CJ, Leake BF, Kim RB, Tirona RG (2010) Human skeletal muscle drug transporters determine local exposure and toxicity of statins. Circ Res 106(2):297–306CrossRefGoogle Scholar
  34. Kocarek TA, Dahn MS, Cai H, Strom SC, Mercer-Haines NA (2002) Regulation of CYP2B6 and CYP3A expression by hydroxymethylglutaryl coenzyme A inhibitors in primary cultured human hepatocytes. Drug Metab Dispos 30(12):1400–1405CrossRefGoogle Scholar
  35. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ Sci Technol 36(6):1202–1211CrossRefGoogle Scholar
  36. Kopecka J, Campia I, Olivero P, Pescarmona G, Ghigo D, Bosia A, Riganti C (2011) A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells. J Control Release 149(2):196–205CrossRefGoogle Scholar
  37. Ku P, Wu X, Nie X, Ou R, Wang L, Su T, Li Y (2014) Effects of triclosan on the detoxification system in the yellow catfish (Pelteobagrus fulvidraco): expressions of CYP and GST genes and corresponding enzyme activity in phase I, II and antioxidant system. Comp Biochem Physiol C Toxicol Pharmacol 166:105–114CrossRefGoogle Scholar
  38. Landmesser U, Bahlmann F, Mueller M, Spiekermann S, Kirchhoff N, Schulz S, Manes C, Fischer D, de Groot K, Fliser D, Fauler G, Marz W, Drexler H (2005) Simvastatin versus ezetimibe—pleiotropic and lipid-lowering effects on endothelial function in humans. Circulation 111(18):2356–2363CrossRefGoogle Scholar
  39. Lech JJ, Vodicnik MJ (1985) Biotransformation. In: Rand GM, Petroceli SR (eds) Fundamentals of aquatic toxicology: methods and applications. Hemisphere Publishing Corporation, New York, pp 526–557Google Scholar
  40. Lee CK, Choi JS, Choi DH (2015) Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of nifedipine in rats: possible role of P-gp and CYP3A4 inhibition by HMG-CoA reductase inhibitors. Pharmacol Rep 67(1):44–51CrossRefGoogle Scholar
  41. Lemahieu WP, Hermann M, Asberg A, Verbeke K, Holdaas H, Vanrenterghem Y, Maes BD (2005) Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus. Am J Transplant 25(9):2236–2243CrossRefGoogle Scholar
  42. Long Y, Li Q, Zhong S, Wang Y, Cui Z (2011) Molecular characterization and functions of zebrafish ABCC2 in cellular efflux of heavy metals. Comp Biochem Physiol C Toxicol Pharmacol 153:381–391CrossRefGoogle Scholar
  43. Lopez-Torres M, Perez-Campo R, Cadenas S, Rojas C, Barja G (1993) A comparative study of free radicals in verebrate. II. Non-enzymatic antioxidants stress. Comp Biochem Physiol B 105:757–763CrossRefGoogle Scholar
  44. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275Google Scholar
  45. Luckenbach T, Fischer S, Sturm A (2014) Current advances on ABC drug transporters in fish. Comp Biochem Physiol C Toxicol Pharmacol 165:28–52CrossRefGoogle Scholar
  46. Machado SP, Cunha V, Reis-Henriques MA, Ferreira M (2014) Histopathological lesions, P-glycoprotein and PCNA expression in zebrafish (Danio rerio) liver after a single exposure to diethylnitrosamine. Environ Toxicol Pharmacol 38(3):720–732CrossRefGoogle Scholar
  47. McCurley AT, Callard GV (2008) Characterization of housekeeping genes in zebrafish: male-female differences and effects of tissue type, developmental stage and chemical treatment. BMC Mol Biol 9, e102CrossRefGoogle Scholar
  48. Mease K, Sane R, Podila L, Taub ME. (2012) Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK-MDR1 monolayers: a strategy to assess the interaction of a new chemical entity with P-gp, BCRP, and MRP2. J Pharm Sci. 101(5):1888–97Google Scholar
  49. Minier C, Lelong C, Djemel N, Rodet F, Tutundjian R, Favrel P, Mathieu M, Leboulenger F (2002) Expression and activity of a multixenobiotic resistance system in the Pacific oyster Crassostrea gigas. Mar Environ Res 54:455–459CrossRefGoogle Scholar
  50. Mo F, Zhao J, Liu N, Cao LH, Jiang SX (2014) Validation of reference genes for RT-qPCR analysis of CYP4T expression in crucian carp. Genet Mol Biol 37(3):500–507CrossRefGoogle Scholar
  51. Navarro A, Weißbach S, Faria M, Barata C, Piña B, Luckenbach T (2012) Abcb and Abcc transporter homologs are expressed and active in larvae and adults of zebra mussel and induced by chemical stress. Aquat Toxicol 15:122–123Google Scholar
  52. Neuparth T, Martins C, de los Santos CB, Costa MH, Martins I, Costa PM, Santos MM (2014) Hypocholesterolaemic pharmaceutical simvastatin disrupts reproduction and population growth of amphipod Gammarus locusta at the ng/L range. Aquat Toxicol 155:337–347CrossRefGoogle Scholar
  53. Ortiz de García SA, Pinto Pinto G, García-Encina PA, Irusta-Mata R (2014) Ecotoxicity and environmental risk assessment of pharmaceuticals and personal care products in aquatic environments and wastewater treatment plants. Ecotoxicology 23(8):1517–1533CrossRefGoogle Scholar
  54. Otte JC, Schmidt AD, Hollert H, Braunbeck T (2010) Spatio-temporal development of CYP1 activity in early life-stages of zebrafish (Danio rerio). Aquat Toxicol 100(1):38–50CrossRefGoogle Scholar
  55. Pereira AM, Silva LJ, Meisel LM, Lino CM, Pena A (2015) Environmental impact of pharmaceuticals from Portuguese wastewaters: geographical and seasonal occurrence, removal and risk assessment. Environ Res 136:108–119CrossRefGoogle Scholar
  56. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9), e45CrossRefGoogle Scholar
  57. Ribeiro S, Torres T, Martins R, Santos MM (2015) Toxicity screening of diclofenac, propanolol, sertraline and simvastatin using Danio rerio and Paracentrotus lividus embryo bioassays. Ecotoxicol Environ Saf 114:67–74CrossRefGoogle Scholar
  58. Sanchez CA, Rodriguez E, Varela E, Zapata E, Paez A, Masso FA, Montano LF, Lopez-Marure R (2008) Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress. Cancer Invest 26(7):698–707CrossRefGoogle Scholar
  59. Santos LH, Araújo AN, Fachini A, Pena A, Delerue-Matos C, Montenegro MC (2010) Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J Hazard Mater 175(1-3):45–95CrossRefGoogle Scholar
  60. Santos MM, Ruivo R, Lopes-Marques M, Torres T, de Los Santos CB, Castro LF, Neuparth T (2016) Statins: an undesirable class of aquatic contaminants? Aquat Toxicol 174:1–9CrossRefGoogle Scholar
  61. Sapone A, Gustavino B, Monfrinotti M, Canistro D, Broccoli M, Pozzetti L, Affatato A, Valgimigli L, Cantelli Forti G, Pedulli FG, Biagi GL, Abdel-Rahman S, Paolini M (2007) Perturbation of cytochrome P450, generation of oxidative stress and induction of DNA damage in Cyprinus carpio exposed in situ to potable surface water. Mutat Res 626:143–154CrossRefGoogle Scholar
  62. Sieczkowski E, Lehner C, Ambros PF, Hohenegger M (2010) Double impact on p-glycoprotein by statins enhances doxorubicin cytotoxicity in human neuroblastoma cells. Int J Cancer 126(9):2025–2035Google Scholar
  63. Soares J, Castro LF, Reis-Henriques MA, Monteiro NM, Santos MM (2012) Zebrafish (Danio rerio) life-cycle exposure to chronic low doses of ethinylestradiol modulates p53 gene transcription within the gonads, but not NER pathways. Ecotoxicology 21(5):1513–1522CrossRefGoogle Scholar
  64. Stegeman JJ, Brouwer M, Di Giulio RT, Förlin L, Fowler BA, Sanders BM, Van Veld PA (1992) Molecular responses to environmental contamination: enzyme and protein systems as indicators of chemical exposure and effect. In: Huggett RJ, Kimerle RA, Mehrle PM, Bergman HL (eds) Biomarkers: biochemical, physiological and histological markers of anthropogenic stress. Lewis Publ, Chelsea, pp 235–335Google Scholar
  65. Tadros W, Lipshitz HD (2009) The maternal-to-zygote transition: a play in two acts. Development 136:3033–3042CrossRefGoogle Scholar
  66. Timme-Laragy AR, Van Tiem LA, Linney EA, Di Giulio RT (2009) Antioxidant responses and NRF2 in synergistic developmental toxicity of PAHs in zebrafish. Toxicol Sci 109(2):217–227CrossRefGoogle Scholar
  67. Torres T (2013) Contribution to the toxicological risk assessment of Simvastatin, Sertraline, 4-MBC, Propylparaben and Triclocarban, under single and combined exposure, using zebrafish and sea urchin embryo bioassays, Master thesis in Toxicology and environmental contamination. Institute of Biomedical Sciences Abel Salazar, University of Porto., p 121Google Scholar
  68. Urbaztka R, Galante-Oliveira S, Rocha E, Castro L, Cunha I (2013) Nornalization strategies for gene expression studies by real-time PCR in marine fish species, Scophthalmus maximus. Mar Genomics 10:17–25CrossRefGoogle Scholar
  69. van der Oost R, Beyer J, Vermeulen NP (2003) Fish bioaccumulation and biomarkers in environmental risk assessment: a review. Environ Toxicol Pharmacol 13:57–149CrossRefGoogle Scholar
  70. Wang E, Casciano C, Clement RP, Johnson W (2001) HMG-CoA redutase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein. Pharmcol Res 18:800–806CrossRefGoogle Scholar
  71. Wassmur B, Gräns J, Norström E, Wallin M, Celander MC (2013) Interactions of pharmaceuticals and other xenobiotics on key detoxification mechanisms and cytoskeleton in Poeciliopsis lucida hepatocellular carcinoma, PLHC-1 cell line. Toxicol In Vitro 27(1):111–120CrossRefGoogle Scholar
  72. Wiegel S, Aulinger A, Brockmeyer R, Harms H, Löffler J, Reincke H, Schmidt R, Stachel B, von Tümpling W, Wanke A (2004) Pharmaceuticals in the river Elbe and its tributaries. Chemosphere 57(2):107–126CrossRefGoogle Scholar
  73. Yamasaki D, Nakamura T, Okamura N, Kokudai M, Inui N, Takeuchi K, Watanabe H, Hirai M, Okumura K, Sakaeda T (2009) Effects of acid and lactone forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on the induction of MDR1 expression and function in LS180 cells. Eur J Pharm Sci 37(2):126–132CrossRefGoogle Scholar
  74. Yang SH, Choi JS, Choi DH (2011) Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of losartan and its main metabolite EXP-3174 in rats: possible role of CYP3A4 and P-gp inhibition by HMG-CoA reductase inhibitors. Pharmacology 88(1-2):1–9CrossRefGoogle Scholar
  75. Zhang Z, Hu J (2007) Development and validation of endogenous reference genes for expression profiling of Medaka (Oryzias latipes) exposed to endocrine disrupting chemicals by quantitative real-time RT-PCR. Toxicol Sci 95:356–368CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • V. Cunha
    • 1
    • 2
  • M. M. Santos
    • 1
    • 3
  • P. Moradas-Ferreira
    • 2
    • 4
    • 5
  • M. Ferreira
    • 1
    • 6
  1. 1.CIIMAR/CIMAR—Interdisciplinary Centre of Marine and Environmental Research, Coastal and Marine Environmental Toxicology LabUniversity of PortoPortoPortugal
  2. 2.ICBAS/UP—Institute of Biomedical Sciences Abel Salazar, University of PortoPortoPortugal
  3. 3.FCUP—Department of Biology, Faculty of SciencesUniversity of PortoPortoPortugal
  4. 4.I3S—Institute for Research and Innovation in Health, University of PortoPortoPortugal
  5. 5.IBMC, Institute for Molecular and Cell BiologyPortoPortugal
  6. 6.School of Marine Studies, Faculty of Science, Technology and EnvironmentThe University of South PacificSuvaFiji Islands

Personalised recommendations